Immuron Limited
IMRNNASDAQHealthcare● Active
$1.20
$-0.05(-4.00%)
Market Cap$7734846
P/E Ratio—
52W High$2.39
52W Low$0.677
Immuron Limited (IMRN) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
IMRN · earnings · updated Jun 9, 2026
Latest Earnings
Q1 FY2026Report Date: Feb 25, 2026EPS Actual
-$0.20
Est. -$0.01 · -2586.2%
Revenue
$0.00B
Est. $0.00B · +3.1%
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Feb 25, 2026
After Market Close
▼ Miss EPS▲ Beat Revenue
IMRN reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 28, 2026 | -$0.00 | — | — | — | $0.00B | — |
| ▼ Q1 FY2026 | Feb 25, 2026 | -$0.01 | -$0.20 | -2586.2% | $0.00B | $0.00B | +3.1% |
| ▼ Q3 FY2025 | Aug 28, 2025 | -$0.01 | -$0.31 | -2219.5% | $0.00B | $0.00B | +7.8% |
| — Q1 FY2025 | Mar 31, 2025 | — | -$0.14 | — | $0.00B | — | — |
| ▼ Q1 FY2025 | Feb 28, 2025 | -$0.01 | -$0.27 | -1922.7% | $0.00B | $0.00B | +48.3% |
| — Q3 FY2024 | Sep 30, 2024 | — | -$0.15 | — | $0.00B | — | — |
| — Q3 FY2024 | Aug 29, 2024 | — | -$0.57 | — | $0.00B | — | — |
| — Q2 FY2024 | Apr 29, 2024 | — | -$0.25 | — | $0.00B | — | — |
Q3 FY2026
Aug 28, 2026
EPS Actual
—
EPS Est.
-$0.00
EPS Surpr.
—
Revenue
—
Q1 FY2026
Feb 25, 2026Miss
EPS Actual
-$0.20
EPS Est.
-$0.01
EPS Surpr.
-2586.2%
Revenue
$0.00B
Q3 FY2025
Aug 28, 2025Miss
EPS Actual
-$0.31
EPS Est.
-$0.01
EPS Surpr.
-2219.5%
Revenue
$0.00B
Q1 FY2025
Mar 31, 2025
EPS Actual
-$0.14
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2025
Feb 28, 2025Miss
EPS Actual
-$0.27
EPS Est.
-$0.01
EPS Surpr.
-1922.7%
Revenue
$0.00B
Q3 FY2024
Sep 30, 2024
EPS Actual
-$0.15
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2024
Aug 29, 2024
EPS Actual
-$0.57
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2024
Apr 29, 2024
EPS Actual
-$0.25
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q2 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2024 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q1 FY2026 | Feb 25, 2026 | -2586.2% | $0.73 | $0.85 | +17.14% |
| ▼ Q3 FY2025 | Aug 28, 2025 | -2219.5% | $1.78 | $1.82 | +2.25% |
| — Q1 FY2025 | Mar 31, 2025 | — | $1.85 | $1.80 | -2.70% |
| ▼ Q1 FY2025 | Feb 28, 2025 | -1922.7% | $1.91 | $1.90 | -0.52% |
| — Q3 FY2024 | Sep 30, 2024 | — | $2.71 | $2.72 | +0.37% |
| — Q3 FY2024 | Aug 29, 2024 | — | $2.66 | $2.66 | +0.00% |
| — Q2 FY2024 | Apr 29, 2024 | — | $2.64 | $2.52 | -4.55% |
| — Q1 FY2024 | Mar 31, 2024 | — | $2.63 | $2.61 | -0.76% |
Q1 FY2026+17.14%
Report Date
Feb 25, 2026
EPS Beat/Miss
-2586.2%
Price Before
$0.73
Price After
$0.85
Q3 FY2025+2.25%
Report Date
Aug 28, 2025
EPS Beat/Miss
-2219.5%
Price Before
$1.78
Price After
$1.82
Q1 FY2025-2.70%
Report Date
Mar 31, 2025
EPS Beat/Miss
—
Price Before
$1.85
Price After
$1.80
Q1 FY2025-0.52%
Report Date
Feb 28, 2025
EPS Beat/Miss
-1922.7%
Price Before
$1.91
Price After
$1.90
Q3 FY2024+0.37%
Report Date
Sep 30, 2024
EPS Beat/Miss
—
Price Before
$2.71
Price After
$2.72
Q3 FY2024+0.00%
Report Date
Aug 29, 2024
EPS Beat/Miss
—
Price Before
$2.66
Price After
$2.66
Q2 FY2024-4.55%
Report Date
Apr 29, 2024
EPS Beat/Miss
—
Price Before
$2.64
Price After
$2.52
Q1 FY2024-0.76%
Report Date
Mar 31, 2024
EPS Beat/Miss
—
Price Before
$2.63
Price After
$2.61
Avg Miss Reaction+6.29%
Beat Rate0 / 8 quarters
Largest Move+17.14% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: IMRN ends December
Immuron Limited (IMRN) most recently reported earnings on February 25, 2026 for Q1 FY2026, posting EPS of $-0.20 — missing the analyst consensus of $-0.01 by -2586.2%. The next IMRN earnings date is expected around September 1, 2026.
Each quarter, investors track IMRN earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. IMRN revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
IMRN's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
IMRN earnings · 5 questionsImmuron Limited's next earnings report is expected around September 1, 2026. IMRN typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; IMRN historically reports after market close (AMC).
IMRN earnings datewhen is IMRN earningsIMRN next earnings datewhen does IMRN report earningsIMRN earnings calendar
▸ Source: FMP · Immuron Limited SEC filings · US GAAP · Immuron Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026